Opposite to its role in leukemia cells, CDK6 was found to drive glycolysis in cervical cancer cells60, which is in line with our findings that CDK6 promotes CAD-mediated RelA deamidation to drive glycolysis in virus-infected oral keratinocytes and endothelial cells. This evidence concerns the gene CAD and cervical cancer.